our technology

We are constantly developing new innovative technologies as we produce veterinary vaccines. Iraka Biotech’s, advanced technology consists of a photonics module coupled to an artificial intelligence engine.

Because of the photonics module, we can create a truly environmentally friendly preparation process for every dose we make. Simultaneously, our artificial intelligence engine ensures the adaptability and traceability of the vaccine production process.

IRAKA BIOTECH PLATFORM TECHNOLOGY

Produces quality vaccines.

Our proprietary configuration allows for both small scale and large-scale vaccine production (between 39 and 585 million doses / annum / facility).

Allows for timely custom vaccine production and speed.

Allows for flexibility of vaccine production.

Highly adaptable and portable machinery.

CONVENTIONAL
TECHNOLOGY

Produces quality vaccines.

Large-scale vaccine production (10 billion doses/ annum).

Does not allow for rapid custom production.

Does not enable the flexibility of vaccine production.

Not adaptable and nor portable.

Our technology is in the process of being protected by a granted patent in specific countries, at this stage a provisional patent application has been filed. However, the company utilizes the technological know-how on vaccine formulation, our trade secret on vaccine-specific inactivation protocols, and a registered trademark as part of our IP strategy.